A review of public information. No hands-on testing, laboratory inspection or medical review is claimed.
The $99 figure needs its qualification
The manufacturer advertises a four-dose box for $99 when commercial insurance does not cover Vyleesi, subject to the program’s eligibility rules. Government-funded insurance beneficiaries are excluded from the assistance program. This is not an unconditional price for every uninsured or insured person.
A box is not a month
Four autoinjectors are the selling unit in the offer. We do not assign a monthly duration or recommend a frequency of use. Delivery through BlinkRx is advertised as free; any separate prescribing visit requires its own cost check.
Our assessment
Vyleesi has a defined approved indication and important contraindications, including uncontrolled hypertension or known cardiovascular disease. The manufacturer says it is not for men, postmenopausal women or enhancing sexual performance. A provider advertising another compounded PT-141 product has not thereby demonstrated equivalence to Vyleesi.
Every offer in our file.
Vyleesi four-dose box
FDA-approved medicineAdvertised offer for eligible patients whose commercial insurance does not cover Vyleesi. Government-program beneficiaries are excluded from the assistance program. Free home delivery through BlinkRx; prescribing-visit cost is not established.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Vyleesi — access, eligibility and safety ↗
Official public information; price and terms checked October 8, 2026.